{
    "2019-04-17": [
        [
            {
                "time": "",
                "original_text": "券商看好医药板块 多只医药指数估值仍待修复",
                "features": {
                    "keywords": [
                        "券商",
                        "医药板块",
                        "指数",
                        "估值",
                        "修复"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "21家公司年报一季报业绩有望双翻番 社保基金重仓持有4只个股",
                "features": {
                    "keywords": [
                        "公司",
                        "年报",
                        "一季报",
                        "业绩",
                        "双翻番",
                        "社保基金",
                        "重仓",
                        "个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}